Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding CalciMedica, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CALC: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders41127−13
Shares11.7M49.5K11.2M−535.6K (−4.6%)
Value$63.7M$269.0K$37.0M−$26.4M (−41.6%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held CalciMedica, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CALC in Q3 2021
InstitutionSharesValue% of portfolio
JPMorgan Chase & Co107,765$358.0K0.00%
Bridgeway Capital Management, LLC90,000$299.0K0.01%
Citadel Advisors LLC81,568$271.0K0.00%
Johnson & Johnson49,547$164.0K0.01%

Sold out (17)

Institutions that held CalciMedica, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Not filed for Q3 2021 yet (1)

Institutions that held CalciMedica, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CALC in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Johnson & Johnson Innovation - JJDC, Inc.49,547$269.0K